Klinische Studie

Prospective, randomized, open, multicenter Phase III trial to investigate the efficacy of active post-resection/ablation therapy in patients with metastatic colorectal cancer(FIRE-9 - PORT / AIO-KRK-0418)Preoperative therapy improves the outcome of patients with resectable colon cancer vs direct surgery followed by adjuvant therapy
EUDRACT2020-006144-18
NCTNCT05008809
DRKS-
Krankheitsentität(en) Darm (Dickdarm, Mastdarm)
Wesentliche EinschlusskriterienBiopsy-confirmed adenocarcinoma of the colon Intent for curative resection 5. Patients with bowel obstruction are only eligible if first stented or defunctioned 6. Tissue is available for pMMR/dMMR testing (centrally and/or locally) Age ≥ 18 at the time of registration
Statusrekrutierend
Ansprechpartner & KontaktÜBAG MVZ Dr. Vehling-Kaiser GmbHVK&K Studien GbRStudienzentrum0871 97403449studien(at)vehling-kaiser.de
zurück